2 Stocks Down 28% and 34% to Buy and Hold
TransMedics Group (TMDX) and SoFi Technologies (SOFI) have seen significant stock declines. TMDX's revenue grew 21% YoY to $189.9M, but profits fell 52%. SOFI's revenue rose 43% to $1.2B, with net income up 61%. Both face near-term challenges but are seen as long-term opportunities.
How this was made
The 30-second read
Why it matters
Earnings releases provide fresh data for valuation models; investors should reassess margin expectations for TMDX and guidance assumptions for SOFI.
Market read
Both stocks have underperformed sharply over the past year; the new earnings data may influence short‑term positioning.
What to watch
TransMedics' upcoming kidney‑transplant approval and SoFi's cryptocurrency‑trading reinstatement may unlock future upside.
Background
The article reviews recent Q2 earnings for TransMedics Group (TMDX) and SoFi Technologies (SOFI), noting revenue growth, earnings miss, and forward outlook.
Ticker impact
TransMedics Group reported Q2 revenue of $189.9M, up 21% YoY, and adjusted EPS of $0.44, 52% lower YoY.
Potential short-term downside as investors digest lower profitability.
Revenue growth is solid, but the steep EPS decline suggests margin pressure.
SoFi posted Q2 revenue of $1.2B (+43% YoY) and net income of $156.6M (+61% YoY), but guidance fell short of estimates.
Stock may see modest volatility as investors weigh growth versus guidance.
Revenue and earnings beat expectations, but high forward PE and weak outlook limit upside.
Market effects
Both companies highlight ongoing volatility in the biotech and fintech sectors as investors balance growth with profitability.
U.S. market sentiment may be tempered by these earnings, especially in the health‑tech and digital banking spaces.
Limited to U.S. investors; no direct global macro impact.
Counterpoint
Despite earnings misses, the long‑term addressable markets for organ‑preservation tech and digital banking could support a rebound.
Key entities
- CompanyTransMedics Group
Developer of Organ Care System for organ preservation.
- CompanySoFi Technologies
Fintech platform offering lending, banking, and crypto services.
